Change in Sweat Chloride as a Clinical End Point in Cystic Fibrosis Clinical Trials: The Ivacaftor Experience

Autor: Durmowicz, Anthony G., Witzmann, Kimberly A., Rosebraugh, Curtis J., Chowdhury, Badrul A.
Zdroj: In Chest January 2013 143(1):14-18
Databáze: ScienceDirect